Clinical Trial Update: TAHP for Patients With HER2-positive Early Breast Cancer and Subsequent AHP Adjuvant tHerapy After Surgery [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for TAHP in HER2-positive breast cancer undergoing adjuvant therapy after surgery, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• AHP
• TAHP

Snippet

Sponsor: Samsung Medical Center | Conditions: HER2-positive Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN